STAT4 and myeloid sarcoma: The IL-12/STAT4 pathway preferentially drives the Th1-like phenotype, prevalent in MS, while the IL-1β/IL-23/RORγt axis promotes the Th17-like phenotype often seen in other contexts 11, 37.